The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue ...

A study, led by scientists from the University of Colorado Anschutz Medical Campus, looked at how viruses could awaken ...

This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their ...

The DNA of nearly all life on Earth contains many redundancies, and scientists have long wondered whether these redundancies served a purpose or if they were just leftovers from evolutionary processes ...

Respiratory infections like Covid-19 and flu may reactivate dormant breast cancer cells in the lungs, increasing metastatic ...

A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at ...

Dr Christopher Evans, a physical medicine expert who led the study, said: 'This could revolutionize the treatment of [this ...

The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, such as the liver, lungs, and spleen. Nevertheless, Ali and Townsend note ...

A modified herpes virus (RP1) combined with immunotherapy showed promising results against advanced melanoma in a clinical ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.

New research shows COVID-19 and flu infections can reactivate dormant breast cancer cells in the lungs, significantly ...